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ABSTRACT
Ineukaryotes asingleclass-1 translationtermination
factor eRF1 decodes the three stop codons: UAA,
UAG and UGA. Some ciliates, like Euplotes, have a
variant code, and here eRF1s exhibit UAR-only
specificity, whereas UGA is reassigned as a sense
codon. Since eukaryote eRF1 stop-codon recogni-
tion is associated with its N-terminal domain,
structural features should exist in the N domain of
ciliate eRF1s that restrict their stop-codon specifi-
city. Using an in vitro reconstituted eukaryotic trans-
lation system we demonstrate here that a chimeric
eRF1 composed of the N domain of Euplotes
aediculatus eRF1 fused to the MC domains of
human eRF1 exhibits UAR-only specificity.
Functional analysis of eRF1 chimeras constructed
by swapping Euplotes N domain sequences with
the cognate regions from human eRF1 as well as
site-directed mutagenesis of human eRF1 high-
lighted the crucial role of the alanine residue in
position 70 of E. aediculatus eRF1 in restricting
UGA decoding. Switching the UAR-only specificity
of E. aediculatus eRF1 to omnipotent mode is
due to a single point mutation. Furthermore, we
examined the influence of eRF3 on the ability of
chimeric and mutant eRF1s to induce peptide
release in response to different stop codons.
INTRODUCTION
The termination of protein synthesis in eukaryotes is
governed by a single polypeptide chain class-1 release
factor eRF1, which recognizes all three stop codons,
UAA, UAG and UGA at the ribosomal A-site when the
P-site is occupied by peptidyl-tRNA (1–3). In eukaryotes,
the highly conserved eRF1 is composed of three well-
deﬁned domains (4,5). The N-terminal domain is respon-
sible for stop codons decoding (6–16), the M (middle)
domain participates in peptidyl-tRNA hydrolysis
(4,17,18) and the C-terminal domain binds to eRF3
(19–24). Class-2 release factor, eRF3 encoded by an essen-
tial gene, is a ribosome- and eRF1-dependent GTPase
(19), which enhances termination efﬁciency by stimulating
the activity of eRF1 (19,25,26).
Many approaches have been used to identify the key
amino acid residues within the N domain of eRF1 that
mediate stop-codon recognition (4,7–16). However, the
data are contradictory.
One possible approach for solving this problem was
to design chimeric eRF1s, which contain different parts
of the N domain of eRF1s from organisms with universal
and variant genetic codes. Exceptions from the standard
genetic code exist in mitochondria, ciliates, Candida and
other species (14). Among the ciliates, Tetrahymena,
Stylonychia and Paramecium species recognize UGA as a
stopcodon,whileUAAandUAGarereassignedtoglutam-
ine codons (27). Euplotes and Blepharisma species decode
UAA and UAG as stop codons but use UGA as cysteine or
tryptophan codons, respectively (28). A chimeric eRF1
with N domain derived from Tetrahymena thermophila
eRF1 and the MC domains from Schizosaccharomyces
pombe was already reported and the amino acid deter-
minants responsible for the UGA-only speciﬁcity of
T. thermophila eRF1 were localized in the N domain
using in an in vitro RF assay (29). In contrast, a chimeric
eRF1 consisting of the N domain of T. thermophila and the
MC domains of Saccharomyces cerevisiae efﬁciently
terminated at all three stop codons when expressed in
yeast cells (30). Thus, the localization of stop-codon deter-
minantsinT.thermophilaeRF1requiresadditionalstudies.
Furthermore, regions sufﬁcient for the UGA-only
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Stylonychia mytilus were identiﬁed in the N-terminal
domain by creating chimeric constructs and using
site-directed mutagenesis (8,16).
The importance of the N domain of E. aediculatus eRF1
and E. octocarinatus eRF1 in determining UAR-only spe-
ciﬁcity was conﬁrmed for interdomain eRF1 chimeras
with MC domains from human and S. cerevisiae eRF1s,
respectively (11,30). Human and Euplotes eRF1s
share signiﬁcant sequence homology, but at least some
of the existing differences between the amino acid se-
quences can be responsible for their different stop-codon
speciﬁcities (Figure 1). In particular, suppressor mutations
which change the stop-codon recognition pattern of
eRF1 were identiﬁed in chimeric proteins carrying
the E. octocarinatus N domain fused to S. cerevisiae MC
domains (31). Nevertheless, the mechanism of stop codon
reassignment in the organisms with variant genetic code is
still poorly understood.
In the current study, we used both a molecular chimera
approach and site-directed mutagenesis followed by
in vitro functional analysis in a reconstituted eukaryotic
translation system; and we have identiﬁed a single amino
acid residue that confers UAR-only speciﬁcity to Euplotes
eRF1 and switches the omnipotent speciﬁcity of human
eRF to UAR-only speciﬁcity. Moreover, we studied the
effect of class-2 eukaryotic translation termination factor
eRF3 on stop-codon decoding of chimeric and mutant
eRF1s as a function of the length of the Euplotes region
in the eRF1 chimera.
MATERIALS AND METHODS
Ampliﬁcation of the sequence encoding the N domain
of the E. aediculatus eRF1b gene
The eRF1b gene sequence encoding the N domain of
E. aediculatus eRF1b was ampliﬁed by PCR from
E. aediculatus cell culture harvested by centrifugation at
11000g for 10min. The cells were slurred in 50mlo f
PCR-mix containing 70mM Tris–HCl, pH 8.6, 16mM
(NH4)2SO4, 2.5mM MgCl2, 0.1% Triton X-100, 0.2mM
of each dNTP, 2mM of each oligonucleotide primer con-
taining NdeI or XhoI restriction site at the 50-end (see
Supplementary Data) and 2.5 U of HiFi DNA-polymerase
(Fermentas). The resulting PCR product corresponding
to the expected length (433bp) of the N domain of
E. aediculatus eRF1b was puriﬁed using a GFX PCR
DNA puriﬁcation kit (GE Healthcare), hydrolyzed with
NdeI and XhoI and ligated in pERF4b-Sal plasmid
treated with NdeI and SalI. pERF4b plasmid contained
the human eRF1 gene with an inserted SalI restriction site
at amino acid positions 144–145 (20). The coding sequence
of the N domain of E. aediculatus eRF1b contained one
UGA codon at amino acid position 132 (numeration of
amino acid position according to human eRF1). This
codon was replaced by a UGC codon for cysteine,
because Euplotes used UGA to encode this amino acid.
The resulting construct was named Eu(1–145) (for details
see Supplementary Data).
Swapping of the N domain sequences between human and
E. aediculatus eRF1s
All constructs were prepared by site-directed mutagenesis
with appropriate primers in two rounds of PCR using
different templates (see Supplementary Data). The result-
ing PCR product was treated with NdeI and SalI endo-
nucleases and inserted into pERF4b-Sal treated with the
same endonucleases.
Point mutations in the N domains of the human and
E. aediculatus eRF1s
The N domains of Hs-eRF1 with substitutions
S70A, G73S, S70A+G73S, V78A, Q79K, Q80E and
E. aediculatus eRF1 with substitutions A70S and
A70S+S73G (residue numbering as in Hs-eRF1) were
obtained by site-directed mutagenesis using the PCR-
based ‘megaprimer’ method as described (12). The result-
ing PCR products were inserted into the plasmid pERF4b.
For cloning details of eRF1 mutants see Supplementary
Data.
Figure 1. Alignment of amino acid sequences from the N-terminal domains of human and Euplotes eRF1s. Residue numbering is that of the human
eRF1. Identical, conserved and semiconserved amino acid residues are black, dark gray and light gray, respectively. The arrow indicates position 70.
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The 40S and 60S ribosomal subunits, as well as eukaryotic
translation factors eIF2, eIF3, eIF4F, eEF1H and eEF2,
were puriﬁed from a rabbit reticulocyte lysate as described
(25). The eukaryotic translation factors eIF1, eIF1A,
eIF4A, eIF4B, eIF5B, eIF5, eRF1, wild-type (wt) eRF1,
mutant and chimeric eRF1s and eRF3 were produced as
recombinant proteins in Escherichia coli strain BL21 with
subsequent protein puriﬁcation on Ni-NTA agarose and
ion-exchange chromatography (17,25).
mRNA transcripts
mRNA was transcribed by T7 RNA polymerase on
MVHL-stop plasmids, contained T7 promoter, four
CAA repeats, the b-globin 50-UTR, and Met, Val, His
and Leu codons followed by one of the three stop
codons (UAA, UAG or UGA) and a 30-UTR comprising
the rest of the natural b-globin coding sequence.
MVHL-stop plasmids (containing UAA, UAG, UGA
stop codons) were obtained as described (32). For
run-off transcription all plasmids were linearized with
XhoI.
Pre-termination complex assembly and puriﬁcation
Pre-termination complexes were assembled as described
(25). Brieﬂy, 37pmol of MVHL-stop mRNAs were
incubated for 30min in buffer A (20mM Tris acetate,
pH 7.5, 100mM KAc, 2.5mM MgCl2,2 m M
dithiothreitol) supplemented with 400U RNase inhibitor
(RiboLock, Fermentas), 1mM ATP, 0.25mM spermidine,
0.2mM GTP, 75mg total tRNA (acylated with Val, His,
Leu and [
35S]Met), 75pmol 40S and 60S puriﬁed riboso-
mal subunits, 125pmol eIF2, eIF3, eIF4F, eIF4A, eIF4B,
eIF1, eIF1A, eIF5, eIF5B each, 200pmol eEF1H and
50pmol eEF2, and then centrifuged in a Beckman SW55
rotor for 95min at 4 C and 50000 r.p.m. in a 10–30%
linear sucrose density gradient prepared in buffer A with
5mM MgCl2. Fractions corresponding to pre-termination
complexes according to optical density and the presence of
[
35S]Met were combined, diluted 3-fold with buffer A
containing 1.25mM MgCl2 (to a ﬁnal concentration of
2.5mM Mg
2+) and used for peptide release assays.
Termination efﬁciency determination
Termination efﬁciency was determined as described (32)
with some modiﬁcations. Aliquots containing 0.0125pmol
of pre-termination complexes assembled in the presence
of [
35S]Met-tRNA were incubated at 37 C with 2.5pmol
of eRF1 for 0–15min or with 0.125pmol eRF1 in presence
of 0.125pmol eRF3 and 0.2mM GTP, 0.2mM MgCl2 for
0–3min. Ribosomes and tRNA were pelleted with ice-cold
5% trichloroacetic acid supplemented with 0.75%
casamino acids and centrifuged at 4 C and 14000g. The
amount of released [
35S]Met-containing tetrapeptide,
which indicated the efﬁciency of peptidyl-tRNA hydroly-
sis, was determined by scintillation counting of super-
natants on an Intertechnique SL-30 liquid scintillation
spectrometer.
Calculation of kcat/KM values
Values of the kcat/KM ratio were determined from kobs.
Under ﬁrst-order conditions at a substrate concentration
far below the estimated KM, the Michaelis–Menten
equation v=(VmS)/(KM+S) became v=(VmS)/KM
since S<<KM or v=(Vm/KM)S=kobs S= dS/dt,
which integrated as lnS= kobst+lnSo, where So is the
starting substrate concentration and S the substrate con-
centration at a given time. Continuous recording of sub-
strate hydrolysis allows determination of kobs from the
graph of lnS versus time. The velocity was proportional
to the substrate concentration. kobs=Vm/KM=(kcatEt)/
KM since Vm=kcatEt, therefore kcat/KM=kobs/Et.
RESULTS
Functional analysis of chimeric eRF1s in various assay
systems
Earlier, using the dual-gene reporter system, we have
shown that two regions in the N domain of E. aediculatus
eRF1 (Eu-eRF1) 38–50 and 123–145 are critical for its
UAR-speciﬁcity [construct Eu-11 (33)]. To conﬁrm these
results, we have tested the chimeric protein Eu(38–50/
123–145) containing the same regions of Eu-eRF1 in a
fully reconstituted in vitro eukaryotic translation system
(25) and in an in vitro RF assay (16,34). Surprisingly,
Eu(38–50/123–145) effectively recognized all three stop
codons in these systems (Supplementary Table S2).
Moreover, we examined the functional activity of this con-
struct in the dual-gene reporter system described in Ref.
(16) but with another stop-codon context. A leaky termin-
ation signal derived from the dystrophin context—GCC
CGG TGT stop GAT AAT TTA from human mRNA
dystrophin transcript variant Dp4271 (35)—was replaced
by the other leaky termination signal—the tobacco mosaic
virus (TMV) context—CAA stop CAA UUA (36). In
the dual-gene reporter system with the TMV context,
the Eu(38-50/123–145) showed no detectable UGA
readthrough increase (Supplementary Table S2).
We measured the functional activity of another chimeric
eRF1 with the N domain of E. aediculatus eRF1 and the
MC domains of the human eRF1 (Hs-eRF1) [Eu(1–145)
construct] in vitro and in vivo. Insigniﬁcant differences
in stop-codon readthrough for this construct have been re-
vealed in an in vivo dual-gene reporter system with TMV
context (Supplementary Table S2), while Eu(1–145) with
the dystrophin context shows strict UAR-only speciﬁcity
and in an in vitro RF-assay described in Ref. (16).
Due to these diverse effects we reanalyzed previously
described eRF1 hybrids in different assay systems. Thus,
the chimera containing the N domain of S. mytilus and the
MC domains of Hs-eRF1 and the Hs-eRF1 TSL_L/
QFM_F mutant [these mutations in positions 122–127
correspond to S. mytilus eRF1 sequence and determine
its UGA-only speciﬁcity (16)] exhibit strong UGA-only
speciﬁcity in an in vitro RF-assay and in the dual gene
reporter system with the TMV context, while for the
dystrophin context practically no increase of readthrough
efﬁciency, i.e. omnipotent speciﬁcity, is observed in the
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Table S2). It follows that the different contexts used in
the dual-gene reporter system lead to ambiguous and con-
troversial results for the same eRF1. Therefore, the
dual-gene reporter system with the dystrophin context
should not be used for functional analysis of eRF1;
earlier results with the dystrophin context pointing to
the importance of regions 38–50 and 123–145 of E.
aediculatus for UAR-only stop-codon speciﬁcity (33) are
therefore questionable.
In the current study, we have used the recently de-
veloped fully reconstituted in vitro eukaryotic translation
system (25) for determining the regions in E. aediculatus
eRF1 crucial for its UAR-only speciﬁcity.
A chimeric protein containing the N-terminal domain of
Eu-eRF1 exhibits UAR-only speciﬁcity
In Euplotes two forms of eRF1 with the same speciﬁcity
(37) are present, viz. eRF1a and eRF1b. Here, we used the
constructs with the N domain of E. aediculatus eRF1b,
because it was shown that eRF1b is more abundant in
Euplotes cells.
The RF activity of chimeric protein (Figure 2A), con-
taining the N-terminal domain of Eu-eRF1 and the MC
domains of Hs-eRF1 [Eu(1–145)] was determined using a
reconstituted eukaryotic translation system consisting of
puriﬁed individual eukaryotic translation factors, 40S and
60S rabbit ribosomal subunits, aminoacylated tRNAs
and synthetic mRNA (25). The rate of peptidyl-tRNA
hydrolysis for different eRF1s was determined as the
amount of
35S-labelled tetrapeptide (MVHL) released as
a function of time from termination complexes in the
presence of UAA (Figure 3A), UAG (Figure 3B) and
UGA (Figure 3C) stop codons. It can be seen from
Figure 3 that Eu(1–145) is active with UAA and UAG
stop codons but that the RF activity towards UGA is
signiﬁcantly decreased, i.e. this protein exhibits mainly
UAR-only speciﬁcity.
The termination efﬁciencies for Hs-eRF1 and Euplotes–
human interdomain chimera were calculated as kcat/KM
values (Table 1, Figure 2B). While Hs-eRF1 shows kcat/KM
values of 2.88 10
4s
 1M
 1 for UAA, 2.57 10
4s
 1M
 1
for UAG and 2.81 10
4s
 1M
 1 for UGA, Eu(1–145)
demonstratesa>5-foldrelativedecreaseofkineticefﬁciency
onlyonUGA stop codon compared to Hs-eRF1.
Region 70–80 of Eu-eRF1 is responsible for UAR-only
speciﬁcity
To ﬁnd the region in the N domain of E. aediculatus eRF1
responsible for UAR-only speciﬁcity, we used a strategy of
isolation of intra-N-domain chimeras (16) containing
swapped fragments from Eu-eRF1 and Hs-eRF1 with
subsequent functional analysis of these proteins in the
reconstituted in vitro eukaryotic translation system.
We selected two points in the Euplotes N domain for
swapping: amino acids 50 and 122 (the numeration of
amino acid positions in all constructs is as in Hs-eRF1,
Figure 2A). In chimera Eu(1–50) the ﬁrst (positions 1–50)
and second (positions 51–145) parts are derived from
Eu-eRF1 and Hs-eRF1, respectively. Eu(1–50) possesses
omnipotent speciﬁcity, its kinetic efﬁciencies at all three
stop codons are comparable with Hs-eRF1. The reciprocal
construct Eu(51–145) demonstrates another pattern of
stop-codon recognition: a relative increase of kinetic efﬁ-
ciency on UAA and UAG is 1.6 and 2.4, respectively;
however, some decrease of efﬁciency is observed on the
UGA stop codon (Table 1, Figure 2B). Thus, the func-
tional pattern for Eu(51–145) corresponds to Eu-eRF1
stop-codon speciﬁcity—the UAA and UAG stop codons
are recognized much more efﬁciently than the UGA
codon. However, the kcat/KM values for this chimera are
higher compared to the kcat/KM values for Hs-eRF1
(Table 1). We suggest that this effect is probably caused
by an increase of the eRF1 afﬁnity towards the ribosomes
as a consequence of amino acid substitutions in Hs-eRF1
important for ribosome binding.
Another pair of inversed chimeras is Eu(1–122) and
Eu(123–145) (Figure 2A). Since the Eu(1–122) possesses
UAR-only speciﬁcity (Table 1, Figure 2B), the determin-
ants preventing the UGA decoding are located in the
region 1–122. Eu(123–145) recognizes all three stop
codons, although a near equal reduction in RF activity
is observed (Table 1, Figure 2B).
The data obtained so far indicate that amino acids re-
sponsible for Euplotes eRF1 stop-codon speciﬁcity lie
between positions 51 and 122. To verify this suggestion,
we used the Eu(51–125) chimera (Figure 2A). The func-
tional activity of Eu(51–125) is similar to that of Eu(51–
145) and conﬁrms the importance of this region for UGA
non-decoding (Table 1, Figure 2B). For the chimera
Eu(51–80), we again observe a signiﬁcant increase of RF
activity in response to UAA and UAG but not to the
UGA stop codon as in the case of Eu(51–145) and
Eu(51–125). In contrast, Eu(81–122) exhibits omnipotent
speciﬁcity typical of Hs-eRF1. Chimera Eu(51–69) reveals
an almost equal increase of kcat/KM values at all three stop
codons (Table 1, Figure 2B). Consequently, the region
corresponding to positions 51–69 of Eu-eRF1 might be
responsible for enhancing eRF1-ribosome binding, and
these amino acids apparently are not involved in UGA
recognition.
Eu(70–80) contains the smallest fragment of Eu-eRF1
sequence and remains still active on UAA and UAG stop
codons, like Hs-eRF1, whereas a signiﬁcant decreased
RF activity on UGA stop codon is observed (Table 1,
Figure 3B). Taken together, these results imply that
amino acid(s) preventing UGA recognition in Eu-eRF1
are located between positions 70–80.
Position 70 in eRF1 is critical for changing stop-codon
speciﬁcity
As is evident from alignment of the N domain amino acid
sequences of Hs-eRF1 and Eu-eRF1, ﬁve variable amino
acid residues are located in the region 70–80 (Figure 1). To
examine the inﬂuence of a single amino acid substitution
in the region 70–80 on RF activity, S70A, G73S, V78A,
Q79K and Q80E Hs-eRF1 mutants were constructed by
site-directed mutagenesis and their activities were assayed
in the reconstituted eukaryotic translation system.
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or V78A in Hs-eRF1, did not affect the kinetic efﬁciency
of the mutant proteins (Table 1, Figure 2B). Replacement
of the glutamine in position 79 by a positively charged
lysine led to an equal increase of kcat/KM values in
response to all three stop codons. In contrast, mutation
Q80E in Hs-eRF1, which eliminates the partial positive
charge, results in a signiﬁcant decrease of termination
efﬁciency at all stop codons (Table 1, Figure 2B). These
effects might be indirect by effecting eRF1 binding to ribo-
somes probably involving rRNA and thus being sensitive
to the charge changes of corresponding amino acid
residues. In any case, the substitutions G73S, V78A,
Q79K and Q80E in Hs-eRF1 are not essential for stop
codon discrimination.
However, the Hs-eRF1 S70A mutant shows a 2.4-fold
reduction of the kinetic efﬁciency in the presence of the
UGA as compared to the wild-type Hs-eRF1 (Table 1,
Figure 3). Thus we suggest that alanine in position 70 of
Eu-eRF1 plays an important role in discrimination against
UGA. To prove this hypothesis, we introduced an A70S
mutation into the chimera Eu(70–80). This construct,
designated Eu(71–80), recognizes all three stop codons
equally well as does Hs-eRF1 (Table 1, Figure 2B). The
fact that the reverse mutation A70S in Eu(70–80) restores
the omnipotent speciﬁcity of the factor conﬁrms the
crucial role of serine in position 70 of Hs-eRF1 for
UGA recognition as stop codon.
Eu(1–145) A70S/S73G mutant exhibits
omnipotent speciﬁcity
To verify the importance of serine in position 70 for UGA
decoding by Hs-eRF1, we substituted alanine for serine in
position 70 in Eu(1–145). Unfortunately, we could not
isolate recombinant protein for mutant Eu(1–145)A70S,
apparently due to the appearance of an E. coli protease
site after A70S substitution (Supplementary Figure S1).
Notably, the chimeric protein Eu(1–145) was not
Figure 2. Chimeric eRF1 constructs containing the whole N-terminal domain of Eu-eRF1 [Eu (1–145)] or swaps between human and Euplotes
sequences within the N-terminal domains (A). All eRF1 constructs contained the MC domain of Hs-eRF1 (positions 146–437). Regions corres-
ponding to E. aediculates and human eRF1s are gray and white, respectively. The numbering of amino acid positions in all constructs is that of
Hs-eRF1. In vitro RF activity of the wild-type, mutant and chimeric eRF1s in response to UAA (gray), UAG (hatched) and UGA (black) stop
codons in the absence (B) and in the presence (C) of human eRF3-GTP (the graphic image data from Tables 1 and 2). Kinetic efﬁciency of eRF1
constructs, kcat/KM, values, were used as an index of RF activity (see ‘Materials and Methods’ section).
Nucleic AcidsResearch, 2011, Vol.39,No. 2 603degraded during its expression in E. coli. Taking into
account that the region 61–77 of Hs-eRF1 and Eu-eRF1
includes two variable amino acid residues in positions 70
and 73 (Figure 1) and that the mutation G73S in Hs-eRF1
does not affect the stop-codon speciﬁcity of the factor
(Table 1, Figure 2B), we have designed a new chimeric
construct with the double mutation A70S/S73G in
Eu(1–145). The termination efﬁciencies of the Eu(1–145)
A70S/S73G mutant were nearly identical to Hs-eRF1 at
all three stop codons (Table 1, Figure 2B), whereas the
reverse double mutant S70A/G73S of Hs-eRF1 revealed
UAR-only speciﬁcity clearly demonstrating the signiﬁ-
cance of the position 70 for UGA decoding.
Discrimination of the eRF1 stop-codon recognition is
augmented by eRF3
Translation termination in eukaryotes is governed by the
cooperative action of two interacting polypeptide chain
factors, eRF1 and eRF3. It is still unknown which step
of the translation termination process is enhanced by the
eRF1–eRF3 interaction. Here, we have examined the
effect of eRF3 on the activities of the chimeric and
mutant eRF1s investigated above.
The termination efﬁciencies (kcat/KM) of six intra-N-
domain chimera eRF1s (Euplotes–human) with
pronounced tendency towards UAR-only speciﬁcity were
monitored in the presence of eRF3-GTP, as well as the
S70A mutant of Hs-eRF1 (UAR-only speciﬁcity) and
Eu(1–145) A70S/S73G mutant (omnipotent stop-codon
speciﬁcity) (Table 2, Figure 4).
The addition of eRF3-GTP increased the termination
efﬁciency of Hs-eRF1 by more than two orders of magni-
tude. In contrast, kcat/KM values of prokaryotic release
factors RF1/RF2 did not change upon RF3-GTP
addition (38). This observation conﬁrms functional differ-
ences between prokaryotic and eukaryotic class-2 release
factors.
Similarly, all examined mutant factors also showed kcat/
KM values about two orders of magnitude larger than
those in the absence of eRF3-GTP (Table 2, Figure 2C).
Interdomain chimera Eu(1–145) exhibited UAR-only spe-
ciﬁcity (Figure 4) with a 10-fold decrease in kinetic efﬁ-
ciency in response to the UGA. However, reducing the
sequence swapped from Eu-eRF1 within the N domain
of chimeric constructs led to the restoration of RF
activity towards UGA up to the omnipotent speciﬁcities
of Eu(70–80) and Hs-eRF1 S70A mutant (Table 2,
Figure 4). We suppose that eRF1 stop-codon recognition
is improved by eRF3. Interestingly, there was no relative
increase of the kcat/KM values for Eu(51–145) and Eu(51–
80) in response to UAA and UAG stop codons, as was
observed earlier without eRF3-GTP. The increase in ter-
mination efﬁciencies after the addition of the eRF3-GTP
by more than two orders of magnitude probably compen-
sates for different eRF1 afﬁnities to the ribosome revealed
in the absence of class-2 release factor.
The mutant Eu(1–145) A70S/S73G recognized all three
stop codons when eRF3-GTP was added to the termin-
ation reaction conﬁrming the crucial importance of the
amino acid residue in position 70 of eRF1 for UGA
recognition.
DISCUSSION
Previously, we evaluated the stop-codon-dependent trans-
lation termination activity of eRF1s by two assays: an
in vivo dual-gene reporter system and an in vitro RF
activity test (16). The relative simplicity of these two
methods is a signiﬁcant advantage but both have
Figure 3. The rate of peptidyl-tRNA hydrolysis with different eRF1s.
35S-labelled tetrapeptide (MVHL) released as a function of time from
termination complexes with UAA (A), UAG (B), UGA (C) stop codons
in the presence of Hs-eRF1 (solid circles) and chimeric or mutant
eRF1s: Eu(1–145) (open circles), Eu(70–80) (solid triangles), S70A
(open triangles). Background release of tetrapeptide in the absence of
eRF1 which was equal to 3–5% from maximum value for Hs-eRF1 was
subtracted in all graphs. A value equal to 1 corresponds to the
maximum value for Hs-eRF1.
604 Nucleic Acids Research, 2011,Vol. 39,No. 2limitations—the absence of natural mRNA, eRF3 and
GTP in the in vitro assay and the presence of endogenous
eRF1/eRF3 in the cell culture used in the in vivo assay.
Moreover, it appeared that the dual-gene reporter system
in some cases was not suitable for determining the
functional activity of chimeric eRF1s. For example,
the E. aediculatus–human hybrid, construct Eu(1–145)
showed contradictory results in the dual reporter system
with different stop codon contexts (Supplementary
Table S2). Another approach for the stop-codon speciﬁ-
city determination of eRF1 consisted in an in vitro
photocrosslinking of Euplotes–human eRF1 hybrids with
in-frame stop codons in 42-mer mRNA analog (11).
However, only the whole N domain of E. aediculatus
appeared to be UAR-speciﬁc and the authors could not
localize determinants preventing UGA recognition via
minimization of the Eu-RF1 sequence.
To avoid these methodological restrictions, in the
current study, we used a fully reconstituted in vitro eu-
karyotic translation system (25). This system consists of
the set of individual components of the translational ap-
paratus which can be varied subject to experimental re-
quirements and approximates the natural system as much
as possible due to the presence of lengthy mRNA with
UTRs and all necessary translation components.
With these improvements, we examined the role of in-
dividual amino acids of eRF1 in governing stop-codon
speciﬁcity. The comparison of the eRF1 sequence from
organisms with universal and variant genetic code
revealed variable residues in the N domains, which is re-
sponsible for the stop-codon speciﬁcity. Two approaches
were used: (i) various regions of the eRF1 N domain were
swapped between ciliate (E. aediculatus) and human
factors, and (ii) amino acid residues within the N
domain were mutated and the activity of the resulting
eRF1s were assessed.
For the ﬁrst time, we determined the kcat/KM values
of the eukaryotic translation termination reaction for
Hs-eRF1 in the presence or absence of eRF3-GTP at dif-
ferent stop codons (Tables 1 and 2). Hs-eRF1 without
Table 1. Kinetic efﬁciencies (kcat/KM) of the wild-type human eRF1 and chimeric or mutant eRF1s
eRF1 UAA
kcat/KM,
s
 1M
 1
UAA relative
decrease/
(increase)
UAG
kcat/KM,
s
 1M
 1
UAG relative
decrease/
(increase)
UGA
kcat/KM,
s
 1M
 1
UGA relative
decrease/
(increase)
Hs-eRF1 2.88 10
4 2.57 10
4 2.81 10
4
Eu(1–145) 2.88 10
4 1.0 2.57 10
4 1.0 5.11 10
3 5.5
Eu(1–50) 2.40 10
4 1.2 1.71 10
4 1.5 1.76 10
4 1.6
Eu(51–145) 4.61 10
4 (1.6) 6.17 10
4 (2.4) 1.76 10
4 1.6
Eu(1–122) 2.22 10
4 1.3 2.14 10
4 1.2 9.06 10
3 3.1
Eu(123–145) 9.30 10
3 3.1 9.18 10
3 2.8 1.00 10
4 2.8
Eu(51–125) 5.76 10
4 (2.0) 5.14 10
4 (2.0) 3.34 10
4 1.2
Eu(51–80) 8.93 10
4 (3.1) 5.14 10
4 (2.0) 2.55 10
4 1.1
Eu(81–122) 2.88 10
4 1.0 3.34 10
4 (1.3) 2.34 10
4 1.2
Eu(51–69) 4.90 10
4 (1.7) 5.65 10
4 (2.2) 4.78 10
4 (1.7)
Eu(70–80) 2.88 10
4 1.0 1.84 10
4 1.4 8.26 10
3 3.4
Eu(71–80) 2.22 10
4 1.3 2.59 10
4 1.0 2.55 10
4 1.1
Hs-eRF1 S70A 2.22 10
4 1.3 2.34 10
4 1.1 1.17 10
4 2.4
Hs-eRF1 G73S 2.40 10
4 1.2 1.98 10
4 1.3 2.35 10
4 1.2
Hs-eRF1 S70A/G73S 2.22 10
4 1.3 1.84 10
4 1.4 6.53 10
3 4.3
Hs-eRF1 V78A 2.87 10
4 1.0 2.57 10
4 1.0 2.34 10
4 1.2
Hs-eRF1 Q79K 6.05 10
4 (2.1) 5.65 10
4 (2.2) 5.62 10
4 (2.0)
Hs-eRF1 Q80E 4.11 10
3 7.0 2.57 10
3 10.0 4.01 10
3 7.0
Eu(1–145)A70S/S73G 2.06 10
4 1.4 1.84 10
4 1.4 1.76 10
4 1.6
The error in kinetic efﬁciency values varied from 0.12 10
4 to 0.35 10
4 for different release factors.
Table 2. Kinetic efﬁciencies (kcat/KM) of the wild-type human eRF1 and chimeric or mutant eRF1s in presence of eRF3
eRF1 UAA
kcat/KM,
s
 1M
 1
UAA relative
decrease/
(increase)
UAG
kcat/KM,
s
 1M
 1
UAG relative
decrease/
(increase)
UGA
kcat/KM,
s
 1M
 1
UGA relative
decrease/
(increase)
Hs-eRF1 4.13 10
6 5.85 10
6 4.80 10
6
Eu(1–145) 3.48 10
6 1.2 4.85 10
6 1.2 4.75 10
5 10.1
Eu(51–145) 1.37 10
6 3.0 1.99 10
6 2.9 4.08 10
5 11.8
Eu(1–122) 1.54 10
6 2.7 3.98 10
6 1.5 7.44 10
5 6.5
Eu(51–125) 4.66 10
6 (1.1) 7.34 10
6 (1.3) 1.80 10
6 2.7
Eu(51–80) 6.70 10
6 (1.6) 3.24 10
6 1.8 7.20 10
5 6.7
Eu(70–80) 3.94 10
6 1.0 6.22 10
6 (1.1) 4.10 10
6 1.2
Hs-eRF1 S70A 3.46 10
6 1.2 8.66 10
6 (1.5) 3.60 10
6 1.3
Eu(1–145)A70S/S73G 2.81 10
6 1.5 6.98 10
6 (1.2) 3.24 10
6 1.5
The error in kinetic efﬁciency values varied from 0.45 10
6 to 0.57 10
6 for different release factors.
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all stop codons and the addition of eRF3 increased all
values more than two orders of magnitude. It should be
noted that the termination efﬁciencies in bacterial system
do not depend upon the presence of RF3-GTP (24)
indicating the functional difference between the eukaryot-
ic and bacterial termination. We suppose that eRF3
directly stimulates eRF1 activity and does not recycle
eRF1 by displacing it from the ribosome after peptide
release as described also for S. cerevisiae termination
factors (26).
Chimeric protein Eu(1–145) exhibited UAR-only speci-
ﬁcity in the reconstituted translation system with  5-fold
relative decrease of the termination efﬁciency towards
the UGA stop codon compared to Hs-eRF1 (Table 1,
Figure 3). The addition of eRF3-GTP improved discrim-
ination against the UGA stop codon (Table 2, Figure 4)
and the corresponding kcat/KM value decreased 10-fold
with respect to Hs-eRF1. However, we did not observe a
complete discrimination against the UGA stop codon for
Eu(1–145). Possible reasons are: (i) system heterogeneity
(the N domain was derived from E. aediculatus eRF1,
while the MC domains were from the human eRF1, and
the ribosomes were isolated from rabbit reticulocyte
lysate), and (ii) additional amino acid residues of eRF1
might be involved in preventing UGA decoding
completely.
We have localized amino acid residues prohibiting
UGA recognition in the region 70–80 of E. aediculatus
eRF1 (Table 1, Figure 3). This area was not considered
earlier to play a decisive role in this function. In different
studies, the following positions were suggested in the N
domain of Hs-eRF1 being important for UGA decoding:
31, 32 (37); 60, 61, 127 (31); regions 38–50 and 123–145
(33). Here, we have unambiguously shown the exceptional
importance of the region 70–80 of E. aediculatus eRF1 in
UGA decoding. The importance of region 51–69 for
ribosome binding might be suggested. The sequences
51–69 of Eu-eRF1 and Hs-eRF1 differ by three amino
acids and include the NIKS-motif (residues 61–64 in
Hu-eRF1) (Figure 1). Earlier, it was shown that region
51–69 effectively cross-linked with the mRNA inside the
ribosome (11). Moreover, the importance of amino acids
60 and 61 for ribosome binding was reported (31).
Site-directed mutagenesis of amino acids from region
70–80 of Hs-eRF1 has revealed that serine substitution
in position 70 is sufﬁcient to turn off the UGA recognition
by the omnipotent factor (Table 1, Figure 3). It probably
occurs due to the loss of the Ser hydroxyl group,
which might be directly involved in UGA recognition of
Hs-eRF1. The insigniﬁcance of the other amino acid
residues in the region 70–80 of Eu-eRF1 for UGA non-
decoding was demonstrated by the ability of Eu(71–80) to
recognize all three stop codons. Furthermore, mutation
A70S in the N domain of E. aediculatus eRF1 fully
restores UGA recognition suggesting that the substitution
in position 70 of E. aediculatus eRF1 is not only necessary
but also sufﬁcient for switching from bipotent to omnipo-
tent speciﬁcity. eRF1 from another ciliate, Blepharisma,
with supposed UAR-only speciﬁcity, also contains a
S70A substitution like Eu-eRF1 supporting our ﬁnding
of the importance of this amino acid for UGA non-
decoding.
Earlier Fan-Minogue et al. (31) demonstrated that some
mutations in the chimeric eRF1, which contained the
N domain of E. octocarinatus and the MC domains of
S. cerevisiae and exhibited UAR-only speciﬁcity,
switched the speciﬁcity from bipotent to omnipotent.
One of the critical mutations was the C124S (numeration
according to S. cerevisiae eRF1), which successfully
Figure 4. The rate of peptidyl-tRNA hydrolysis with different eRF1s
in the presence of eRF3-GTP.
35S-labelled tetrapeptide (MVHL)
released as a function of time from termination complexes with UAA
(A), UAG (B), UGA (C) stop codons in the presence of Hs-eRF1 (solid
circles) and chimeric or mutant eRF1s: Eu(1–145) (open circles),
Eu(70–80) (solid triangles), S70A (open triangles). Background release
of tetrapeptide in the absence of eRF1 which was equal to 3–5% from
maximum value for Hs-eRF1 was subtracted in all graphs. A value
equal to 1 corresponds to the maximum value for Hs-eRF1 in the
presence of eRF3-GTP.
606 Nucleic Acids Research, 2011,Vol. 39,No. 2restored efﬁcient recognition of the UGA stop codon
without signiﬁcant effect on UAA and UAG. However,
this amino acid residue is located inside of the YxCxxxF
motif, which is universally conserved among all known
eukaryotic class-1 release factors and therefore cannot
take part in switching the stop-codon recognition
pattern. To verify the importance of C127 (numeration
according to Hs-eRF1) in determining of the
UAR-speciﬁcity of Euplotes, two point mutations,
C127S and C127A, were introduced into the chimeric
Eu(1–145) construct described above, and functional
activity was measured in the reconstituted eukaryotic
translational system. Both mutant eRF1s exhibited negli-
gible RF activity on all three stop codons (Supplementary
Table S2). It is thus likely that C127 in eRF1 is necessary
for supporting the N domain overall structure or, alterna-
tively, it is important for UAR decoding since Eu(1–145)
does not recognize the UGA stop codon.
Though in the absence of eRF3-GTP the Hs-eRF1
S70A mutant exhibits UAR-only speciﬁcity (Table 1,
Figure 3), in the presence of eRF3-GTP, the mutant
factor recognizes all three stop codons (Table 2,
Figure 4). The same inﬂuence of eRF3-GTP on
stop-codon speciﬁcity was revealed for Eu(70–80).
Extending the sequence from Eu-eRF1 in chimeric con-
structs reduced the inﬂuence of eRF3-GTP on the RF
activity in the presence of the UGA stop codon
(Table 2, Figure 4). Eu(51–80) is the minimal construct
in our chimera collection, which exhibits UAR-only spe-
ciﬁcity in the presence of eRF3-GTP. Thus, eRF3
improves the eRF1 stop codon decoding during eukaryot-
ic translation termination.
Taken together, our results demonstrate that a single
amino acid mutation can restore UGA recognition by
Euplotes eRF1. The amino acid in position 70 is decisive
for the stop-codon-recognition speciﬁcity of eRF1: S70
mediates omnipotent and A70 bipotent speciﬁcity.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Sergey Lekomtsev and Peter Kolosov for con-
struction of some chimeric eRF1 genes, Maria Rautian for
providing us Euplotes sp. culture, Andrey Poltaraus and
his colleagues for sequencing mutant eRF1 genes. We are
grateful to Tatyana Pestova and Chris Hellen who
provided us with recombinant plasmids encoding initi-
ation factors. We thank Richard D’Ari for help with the
article and two referees for valuable comments and
criticism.
FUNDING
Russian Foundation for Basic Research (08-04-01091-‘ to
E.A., 08-04-00375a to L.F.); the Program on Molecular
and Cellular Biology of the Russian Academy of Sciences
(to L.F.); the President of the Russian Federation
(MK-4705.2009.4 to E.A.). Funding for open access
charge: Personal funds of Ludmila Frolova.
Conﬂict of interest statement. None declared.
REFERENCES
1. Kisselev,L.L., Ehrenberg,M. and Frolova,L.Yu. (2003)
Termination of translation: interplay of mRNA, rRNAs and
release factors. EMBO J., 22, 175–182.
2. Nakamura,Y. and Ito,K. (2003) Making sense of mimic in
translation termination. Trends Biochem. Sci., 28, 99–105.
3. Poole,E.S., Askarian-Amiri,M.E., Major,L.L., McCaughan,K.K.,
Scarlett,D.J., Wilson,D.N. and Tate,W.P. (2003) Molecular
mimicry in the decoding of translational stop signals. Prog.
Nucleic Acid Res. Mol. Biol., 74, 83–121.
4. Song,H., Mugnier,P., Webb,H.M., Evans,D.R., Tuite,M.F.,
Hemmings,B.A. and Barford,D. (2000) The crystal structure of
human eukaryotic release factors eRF1—mechanism of stop
codon recognition and peptidyl-tRNA hydrolysis. Cell, 100,
311–321.
5. Frolova,L.Y., Merkulova,T.I. and Kisselev,L.L. (2000)
Translation termination in eukaryotes: polypeptide release factor
eRF1 is composed of functionally and structurally distinct
domains. RNA, 6, 381–390.
6. Bertram,G., Bell,H.A., Ritchie,D.W., Fullerton,G. and
Stansﬁeld,I. (2000) Terminating eukaryote translation: domain 1
of release factor eRF1 functions in stop codon recognition. RNA,
6, 1236–1247.
7. Frolova,L., Seit-Nebi,A. and Kisselev,L. (2002) Highly conserved
NIKS tetrapeptide is functionally essential in eukaryotic
translation termination factor eRF1. RNA, 8, 129–136.
8. Seit-Nebi,A., Frolova,L. and Kisselev,L. (2002) Conversion of
omnipotent translation termination factor eRF1 into ciliate-like
UGA-only unipotent eRF1. EMBO Rep., 3, 881–886.
9. Chavatte,L., Seit-Nebi,A., Dubovaya,V. and Favre,A. (2002)
The invariant uridine of stop codons contacts the conserved
NIKSR loop of human eRF1 in the ribosome. EMBO J., 21,
5302–5311.
10. Inagaki,Y., Bloin,C., Doolitle,W.F. and Roger,A.J. (2002)
Convergence and constraint in eukaryotic release factor (eRF1)
domain 1: the evolution of stop codon speciﬁcity. Nucleic Acids
Res., 30, 532–544.
11. Chavatte,L., Kervestin,S., Favre,A. and Jean-Jean,O. (2003) Stop
codon selection in eukaryotic translation termination: comparison
of the discriminating potential between human and ciliate eRF1s.
EMBO J., 22, 1644–1653.
12. Kolosov,P., Frolova,L., Seit-Nebi,A., Dubovaya,V.,
Kononenko,A., Oparina,N., Justesen,J., Eﬁmov,A. and
Kisselev,L. (2005) Invariant amino acids essential for decoding
function of polypeptide release factor eRF1. Nucleic Acids Res.,
33, 6418–6425.
13. Kim,O.T., Yura,K., Go,N. and Harumoto,T. (2005) Newly
sequenced eRF1s from ciliates: the diversity of stop codon usage
and the molecular surfaces that are important for stop codon
interactions. Gene, 346, 277–286.
14. Liang,H., Wong,J.Y., Bao,Q., Cavalcanti,A.R. and
Landweber,L.F. (2005) Decoding the decoding region: analysis of
eukaryotic release factor (eRF1) stop codon-binding residues.
J. Mol. Evol., 60, 337–344.
15. Muramatsu,T., Heckmann,K., Kitanaka,C. and Kuchino,Y.
(2001) Molecular mechanism of stop codon recognition by eRF1:
a wobble hypothesis for peptide anticodons. FEBS Lett., 488,
105–109.
16. Lekomtsev,S., Kolosov,P., Bidou,L., Frolova,L., Rousset,J.P. and
Kisselev,L. (2007) Different modes of stop codon restriction by
the Stylonychia and Paramecium eRF1 translation termination
factors. Proc. Natl Acad. Sci. USA, 104, 10824–10829.
17. Frolova,L.Y., Tsivkovskii,R.Y., Sivolobova,G.F., Oparina,N.Y.,
Serpinsky,O.I., Blinov,V.M., Tatkov,S.I. and Kisselev,L.L. (1999)
Mutations in the highly conserved GGQ motif of class 1
Nucleic AcidsResearch, 2011, Vol.39,No. 2 607polypeptide release factors abolish ability of human eRF1 to
trigger peptidyl-tRNA hydrolysis. RNA, 5, 1014–1020.
18. Seit-Nebi,A., Frolova,L., Justesen,J. and Kisselev,L. (2001)
Class-1 translation termination factors: invariant GGQ
minidomain is essential for release activity and ribosome binding
but not for stop codon recognition. Nucleic Acids Res., 29,
3982–3987.
19. Zhouravleva,G., Frolova,L., Le Goff,X., Le Guellec,R., Inge-
Vechtomov,S., Kisselev,L. and Philippe,M. (1995) Termination of
translation in eukaryotes is governed by two interacting
polypeptide chain release factors, eRF1 and eRF3. EMBO J., 14,
4065–4072.
20. Stansﬁeld,I., Jones,K.M., Kushnirov,V.V.,
Dagkesamanskaya,A.R., Poznyakovski,A.I., Paushkin,S.V.,
Nierras,C.R., Cox,B.S., Ter-Avanesyan,M.D. and Tuite,M.F.
(1995) The products of the SUP45 (eRF1) and SUP35 genes
interact to mediate translation termination in Saccharomyces
cerevisiae. EMBO J., 14, 4365–4373.
21. Ito,K., Ebihara,K. and Nakamura,Y. (1998) The stretch of
C-terminal acidic amino acids of translational release factor eRF1
is a primary binding site for eRF3 of ﬁssion yeast. RNA, 4,
958–972.
22. Merkulova,T.I., Frolova,L.Y., Lazar,M., Camonis,J. and
Kisselev,L.L. (1999) C-terminal domains of human translation
termination factors eRF1 and eRF3 mediate their in vivo
interaction. FEBS Lett., 443, 41–47.
23. Eurwilaichitr,L., Graves,F.M., Stansﬁeld,I. and Tuite,M.F. (1999)
The C-terminus of eRF1 deﬁnes a functionally important
domain for translation termination in Saccharomyces cerevisiae.
Mol. Microbiol., 32, 485–496.
24. Cheng,Z., Saito,K., Pisarev,A.V., Wada,M., Pisareva,V.P.,
Pestova,T.V., Gajda,M., Round,A., Kong,C., Lim,M. et al. (2009)
Structural insights into eRF3 and stop codon recognition by
eRF1. Genes Dev., 23, 1106–1118.
25. Alkalaeva,E.Z., Pisarev,A.V., Frolova,L.Y., Kisselev,L.L. and
Pestova,T.V. (2006) In vitro reconstitution of eukaryotic
translation reveals cooperativity between release factors eRF1 and
eRF3. Cell, 125, 1125–1136.
26. Salas-Marco,J. and Bedwell,D.M. (2004) GTP hydrolysis by eRF3
facilitates stop codon decoding during eukaryotic translation
termination. Mol. Cell Biol., 24, 7769–7778.
27. Horowitz,S. and Gorovsky,M.A. (1985) An unusual genetic code
in nuclear genes of Tetrahymena. Proc. Natl Acad. Sci. USA, 82,
2452–2455.
28. Meyer,F., Schmidt,H.J., Plumper,E., Hasilik,A., Mersmann,G.,
Meyer,H.E., Engstrom,A. and Heckmann,K. (1991) UGA is
translated as cysteine in pheromone 3 of Euplotes octocarinatus.
Proc. Natl Acad. Sci. USA, 88, 3758–3761.
29. Ito,K., Frolova,L., Seit-Nebi,A., Karamyshev,A., Kisselev,L. and
Nakamura,Y. (2002) Omnipotent decoding potential resides in
eukaryotic translation termination factor eRF1 of variant-code
organisms and is modulated by the interactions of amino acid
sequences within the domain 1. Proc. Natl Acad. Sci. USA, 99,
8494–8499.
30. Salas-Marco,J., Fan-Minogue,H., Kallmeyer,A.K.,
Klobutcher,L.A., Farabaugh,P.J. and Bedwell,D.M. (2006)
Distinct paths to stop codon reassignment by the variant-code
organisms Tetrahymena and Euplotes. Mol. Cell. Biol., 26,
438–447.
31. Fan-Minogue,H., Du,M., Pisarev,A.V., Kallmeyer,A.K.,
Salas-Marco,J., Keeling,K.M., Thompson,S.R., Pestova,T.V. and
Bedwell,D.M. (2008) Distinct eRF3 requirements suggest alternate
eRF1 conformations mediate peptide release during eukaryotic
translation termination. Mol. Cell, 30, 599–609.
32. Alkalaeva,E., Eliseev,B., Ambrogelly,A., Vlasov,P.,
Kondrashov,F.A., Gundllapalli,S., Frolova,L., So ¨ ll,D. and
Kisselev,L. (2009) Translation termination in pyrrolysine-utilizing
archaea. FEBS Lett., 583, 3455–3460.
33. Lekomtsev,S.A., Kolosov,P.M., Frolova,L.Yu., Bidou,L.,
Rousset,J.P. and Kiselev,L.L. (2007) How translation termination
factor eRF1 Euplotes does not recognise UGA stop codon.
Mol. Biol., 41, 1014–1022.
34. Caskey,C., Beaudet,A.L. and Tate,W.P. (1974) Mammalian
release factor: in vitro assay and puriﬁcation. Methods Enzymol.,
30, 293–303.
35. Nigro,V., Politano,L., Nigro,G., Romano,S.C., Molinari,A.M.
and Puca,G.A. (1992) Detection of a nonsense mutation in
the dystrophin gene by multiple SSCP. Hum. Mol. Genet., 1,
517–520.
36. Pelham,H.R. (1978) Leaky UAG termination codon in tobacco
mosaic virus RNA. Nature, 272, 469–471.
37. Wang,Y., Chai,B., Wang,W. and Liang,A. (2010) Functional
characterization of polypeptide release factor 1b in the ciliate
Euplotes. Biosci. Rep., [Epub ahead of print] PMID: 20136636
February 8, 2010.
38. Freistroffer,D.V., Pavlov,M.Y., MacDougall,J., Buckingham,R.H.
and Ehrenberg,M. (1997) Release factor RF3 in E.coli
accelerates the dissociation of release factors RF1 and RF2
from the ribosome in a GTP-dependent manner. EMBO J., 16,
4126–4133.
608 Nucleic Acids Research, 2011,Vol. 39,No. 2